Related Articles
In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.
Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells
Antitumor effect of trimelamol against human breast carcinoma xenografts in nude mice